• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物从气道和肺部的摄取。

Drug uptake from the airways and lungs.

作者信息

Widdicombe J

机构信息

Sherrington School of Physiology, St. Thomas' Campus (UMDS), London, U.K.

出版信息

Indian J Physiol Pharmacol. 1998 Jan;42(1):3-14.

PMID:9513788
Abstract

This paper reviews the mechanisms and physiological processes that act when drugs or chemicals are administered into the lower airways and lungs. Administration is usually by aerosol. Agents can be given, for example, either to treat pulmonary diseases such as asthma, or the test for airways' responsiveness or other functions, or as a means of access of a drug to the systemic circulation. The first barrier to absorption is the airway surface liquid, including mucus. The thickness of this layer will determine the concentration of the drug in solution, and therefore its rate of entry into the tissue. The agent must then penetrate the airway epithelium, the strongest barrier for hydrophilic agents. Agents must then diffuse through the epithelial basement membrane and the interstitium. Finally, the agent may be taken up into the mucosal vasculature, and changes in blood flow will influence its uptake and distribution. If the drug is to reach a target organ, such as airway smooth muscle or glands, these barriers have first to be traversed.

摘要

本文综述了药物或化学物质经气道下段和肺部给药时所涉及的作用机制和生理过程。给药通常采用气雾剂形式。例如,给药的目的可以是治疗诸如哮喘之类的肺部疾病,或检测气道反应性或其他功能,或作为药物进入体循环的一种途径。吸收的第一道屏障是气道表面液体,包括黏液。这一层的厚度将决定溶液中药物的浓度,进而决定其进入组织的速率。然后,药物必须穿透气道上皮,这是亲水性药物最强的屏障。接着,药物必须扩散穿过上皮基底膜和间质。最后,药物可能会被吸收进入黏膜血管,血流的变化将影响其吸收和分布。如果药物要到达靶器官,如气道平滑肌或腺体,就必须首先穿过这些屏障。

相似文献

1
Drug uptake from the airways and lungs.药物从气道和肺部的摄取。
Indian J Physiol Pharmacol. 1998 Jan;42(1):3-14.
2
Permeability of the airway mucosa in asthma.
Eur Respir J Suppl. 1991 Apr;13:139s-147s.
3
[Non-ventilatory functions of the cells of the respiratory system].[呼吸系统细胞的非通气功能]
Ann Biol Clin (Paris). 1982;40(3):209-19.
4
Effects of concentrated ambient particles on normal and hypersecretory airways in rats.浓缩环境颗粒物对大鼠正常和分泌亢进气道的影响。
Res Rep Health Eff Inst. 2004 Aug(120):1-68; discussion 69-79.
5
Absorption capacity of the upper airway and lungs. Part I. General concepts.上呼吸道和肺部的吸收能力。第一部分。一般概念。
Mich Med. 1975 Feb;74(6):81-2, 85.
6
Structural changes in the airways in asthma: observations and consequences.哮喘气道的结构变化:观察结果与影响
Clin Sci (Lond). 2005 Jun;108(6):463-77. doi: 10.1042/CS20040342.
7
[The mucociliary system of the lung--role of surfactants].[肺的黏液纤毛系统——表面活性剂的作用]
Schweiz Med Wochenschr. 2000 May 13;130(19):691-8.
8
The particle has landed--characterizing the fate of inhaled pharmaceuticals.粒子已经着陆——描述吸入式药物的命运。
J Aerosol Med Pulm Drug Deliv. 2010 Dec;23 Suppl 2:S71-87. doi: 10.1089/jamp.2010.0836.
9
Mild dehydration: a risk factor of broncho-pulmonary disorders?轻度脱水:支气管肺部疾病的一个风险因素?
Eur J Clin Nutr. 2003 Dec;57 Suppl 2:S81-7. doi: 10.1038/sj.ejcn.1601906.
10
[Correlation of reticular basement membrane thickness and airway wall remolding in asthma patients].[哮喘患者网状基底膜厚度与气道壁重塑的相关性]
Zhonghua Yi Xue Za Zhi. 2006 Feb 21;86(7):468-71.